Molecular techniques in monitoring minimal residual disease in leukemia

The main reason is the persistence of cancer cells after treatment. Detecting minimal residual disease is considered as “gold standard” in evaluating treatment efficiency, selecting alternative therapies, and predicting relapse in leukemic management.